As a competitive inhibitor of Gal-3, MCP binds to intracellular and extracellular Gal-3, reduces level of Gal-3 and prevents cardiac fibrosis, inflammation and functional alterations associated in a number of experimental animal models [35, 40, 43]. Here, LGALS3 is linked to fibrosis.